ATOSSA THERAPEUTICS, INC. Quarterly Other Assets, Noncurrent in USD from Q4 2011 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Atossa Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q4 2011 to Q2 2024.
  • Atossa Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending June 30, 2024 was $2.43M, a 279% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $2.43M +$1.79M +279% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $2.32M +$1.69M +268% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $2.32M +$1.69M +266% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $2.34M +$1.71M +272% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $642K +$15K +2.39% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $631K +$1K +0.16% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $635K +$613K +2786% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $629K +$616K +4591% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $627K +$614K +4576% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $630K +$614K +3726% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $22K +$5K +29.4% Dec 31, 2021 10-K 2023-03-22
Q3 2021 $13.4K -$3.81K -22.1% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $13.4K -$3.81K -22.1% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $16.5K -$750 -4.36% Mar 31, 2021 10-Q 2021-05-14
Q4 2020 $17K -$218 -1.27% Dec 31, 2020 10-K 2022-02-28
Q3 2020 $17.2K $0 0% Sep 30, 2020 10-Q 2020-11-13
Q2 2020 $17.2K $0 0% Jun 30, 2020 10-Q 2020-08-13
Q1 2020 $17.2K $0 0% Mar 31, 2020 10-Q 2020-05-13
Q4 2019 $17.2K $0 0% Dec 31, 2019 10-K 2021-03-31
Q3 2019 $17.2K -$71.3K -80.5% Sep 30, 2019 10-Q 2019-11-13
Q2 2019 $17.2K -$31.6K -64.8% Jun 30, 2019 10-Q 2019-08-13
Q1 2019 $17.2K -$97.4K -85% Mar 31, 2019 10-Q 2019-05-13
Q4 2018 $17.2K -$162K -90.4% Dec 31, 2018 10-K 2020-03-26
Q3 2018 $88.5K -$20.2K -18.6% Sep 30, 2018 10-Q 2018-11-14
Q2 2018 $48.9K -$79.7K -62% Jun 30, 2018 10-Q/A 2018-11-13
Q1 2018 $115K -$34K -22.9% Mar 31, 2018 10-Q 2018-05-14
Q4 2017 $179K -$15.3K -7.9% Dec 31, 2017 10-K 2019-03-28
Q3 2017 $109K -$119K -52.3% Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $129K -$140K -52.1% Jun 30, 2017 10-Q 2017-08-14
Q1 2017 $149K +$72.2K +94.6% Mar 31, 2017 10-Q 2017-05-11
Q4 2016 $194K +$118K +154% Dec 31, 2016 10-K 2018-03-08
Q3 2016 $228K +$175K +333% Sep 30, 2016 10-Q/A 2017-03-21
Q2 2016 $268K +$216K +410% Jun 30, 2016 10-Q/A 2017-03-21
Q1 2016 $76.3K -$100K -56.8% Mar 31, 2016 10-Q/A 2017-03-21
Q4 2015 $76.3K +$28.1K +58.4% Dec 31, 2015 10-Q/A 2017-03-21
Q3 2015 $52.6K Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $52.6K Jun 30, 2015 10-Q 2015-08-06
Q1 2015 $177K -$4.38M -96.1% Mar 31, 2015 10-Q 2015-05-13
Q4 2014 $48.2K +$11.7K +32.2% Dec 31, 2014 10-K 2016-03-30
Q1 2014 $4.55M -$42.8K -0.93% Mar 31, 2014 10-Q 2014-05-14
Q4 2013 $36.4K -$4.64M -99.2% Dec 31, 2013 10-K 2015-03-30
Q3 2013 $4.44M -$296K -6.25% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $4.49M Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $4.6M Mar 31, 2013 10-Q 2013-05-15
Q4 2012 $4.68M +$4.63M +10067% Dec 31, 2012 10-K 2014-03-27
Q3 2012 $4.74M Sep 30, 2012 10-Q/A 2013-01-22
Q4 2011 $46K Dec 31, 2011 10-K 2013-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.